Macrophage USP7 aggravates acute myocardial infarction by inhibiting STING degradation through the ESCRT pathway

Wenqian Qi1, Ruiqing Ren1, Liwen Yu1

  • 1State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.

Insights

USP7 deubiquitinating enzyme regulates STING ubiquitination and degradation, suppressing cardiac inflammation in acute myocardial infarction (AMI). USP7 inhibition offers a potential therapeutic strategy for AMI by reducing macrophage inflammatory responses.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Biology

Background:

  • Macrophage-driven inflammation is central to acute myocardial infarction (AMI) progression.
  • Elevated USP7 expression is observed in peripheral blood mononuclear cells (PBMCs) of coronary artery disease (CAD) patients.

Purpose of the Study:

  • To investigate the role of USP7 in macrophage-mediated inflammation during AMI.
  • To elucidate the molecular mechanism by which USP7 influences STING signaling and cardiac injury.

Main Methods:

  • Macrophage-specific USP7 knockout mouse model of myocardial infarction (MI).
  • Analysis of STING ubiquitination, degradation via the ESCRT-lysosomal pathway, and inflammatory signaling.
  • Pharmacological inhibition and adenovirus-mediated knockdown of USP7.

Main Results:

  • Macrophage-specific USP7 knockout suppressed cardiac inflammation post-AMI in mice.
  • USP7 directly interacted with STING, suppressing its K63-linked ubiquitination at K289 and preventing degradation.
  • USP7 ablation's cardioprotective effects were reversed by STING overexpression.
  • USP7 inhibition or knockdown attenuated AMI-induced cardiac injury and inflammation.

Conclusions:

  • USP7 is a novel deubiquitinating enzyme regulating STING ubiquitination and degradation through the ESCRT pathway.
  • USP7 critically controls macrophage inflammatory responses in the context of AMI.
  • Targeting USP7 presents a potential therapeutic avenue for mitigating cardiac inflammation in AMI.